COMP <GO>
MGTX vs DNA // REVENUE GROWTH (YOY)
MeiraGTx Holdings plc (NASDAQ) VS. Ginkgo Bioworks Holdings Inc. (Class A) (NYSE) • 15-METRIC TALLY: MGTX 3
— DNA 2
▲ REVENUE GROWTH (YOY) LEADER: MGTX
LAST: $9.49 (-2.21%) • MKT CAP: $932.1M
revenue-growth
144.60%
LAST: $11.21 (-12.01%) • MKT CAP: $819.7M
revenue-growth
-25.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MGTX VS. DNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MGTX | DNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.38% | -21.80% | +16.42 | MGTX | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -0.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 144.60% | -25.10% | +169.70 | MGTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | DNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.9 | 58.4 | -16.50 | DNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $932.1M | $819.7M | $112.4M | MGTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MGTX REV | DNA REV | MGTX GROSS % | DNA GROSS % | MGTX FCF | DNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $81.4M | $170.2M | — | — | -$50.2M | -$178.7M |
| FY 2024 | $33.3M | $227.0M | — | — | -$109.5M | -$382.1M |
| FY 2023 | $14.0M | $251.5M | — | — | -$105.4M | -$295.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MGTX // BETA —
DNA // BETA —